Le Lézard
Classified in: Health
Subjects: CHI, SVY

Pediatric Health Care Products and Services Market to Collect US$ 130,000 Mn and US$ 830,000 Mn, Respectively in 2026 - TMR


ALBANY, New York, June 5, 2018 /PRNewswire/ --

Transparency Market Research (TMR) has published a new report titled, "Pediatric Healthcare Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 - 2026". According to the report, the global pediatric health care products and services market was valued at US$ 88,000 Mn and US$ 520,000 Mn, respectively, in 2017 and is projected to expand at a CAGR of 4.5% and 5.5% from 2018 to 2026. Rise in disorders and diseases among children is expected to drive demand for drugs used in the treatment of these conditions from 2018 to 2026.

     (Logo: https://mma.prnewswire.com/media/664869/Transparency_Market_Research_Logo.jpg )

Increase in funding for research on pediatric disorders, especially in countries such as the U.S., the U.K., and Germany, is expected to result in new treatment options for the management of various ailments in children. Rise in number of children with disorders and diseases such as allergies, asthma and other respiratory disorders, high blood pressure, obesity, mental disorders, and infectious diseases drives the global market. Moreover, increasing awareness levels about pediatric health, rise in the number of programs targeted towards safeguarding the interests and rights of the children along with promoting comprehensive development in them are expected to help in improving the overall well-being of children and boost the growth of the market during the forecast period.

Read Report Overview: https://www.transparencymarketresearch.com/pediatric-health-care-products-services-market.html

Countries across the globe are partnering with the industry in order to develop novel drugs for addressing concerns arising due to resistance developed by microorganisms toward antibiotic drugs. These initiatives are anticipated to channelize more investments for developing new and improved medicines to be used for combating antibiotic-resistant bacteria. Major pharmaceutical companies are focusing on new product launches along with expanding the indications of existing drugs for pediatric patients in order to tap into the large unmet needs and also subsequently boost their market share. These factors are likely to accelerate the growth of the market during the forecast period. However, stringent regulatory requirements are likely to restrain the market.

Request a PDF sample at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12236

The report offers detailed segmentation of the global pediatric health care products and services market based on drug class, diseases/disorders, and services type. In terms of drug class, the antibiotics segment is projected to capture major share of the market from 2018 to 2026. Significant market share of the segment is attributed to high prescription rates for antibiotics among children and inclination toward self-medication particularly in low income countries. The antidepressants segment is likely to account for 4.0% market share by 2026 due to rise in the number of children and adolescents affected with depression and anxiety across the world.

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12236

Allergy and Respiratory Segment to Capture for Major Share 

The allergy and respiratory segment is likely to account for the major share of the market by 2026. The segment is expected to expand at a high growth rate during the forecast period. Growth of the segment is attributed to rise in demand for pediatric health care products for allergy and respiratory disorders. The hormonal imbalance segment held 4.0% market share in 2017.

Other Pediatric Health Care Services Segment to Account for Dominant Share 

The other pediatric health care services segment is anticipated to capture for dominant share of the global pediatric health care products and services market during the forecast period owing to rise in burden of diseases and disorders such as infectious diseases, allergies, asthma, and other respiratory conditions among children. Moreover, increase in emphasis on newborn screening programs focused on detecting various health conditions in infants is expected to boost the growth of the segment from 2018 to 2026.

Request a Custom Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=12236

Asia Pacific to Grow at Rapid Pace 

North America accounted for the leading share of the global pediatric health care products and services market in 2017. Substantial market share of the region is due to launch of new drugs by pharmaceutical companies targeted at pediatric patients. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period, driven by increase in number of children with diseases and disorders and improvement in health care infrastructure in countries such as China, India, and Indonesia.

Pfizer, Inc., GlaxoSmithKline plc, and Merck & Co., Inc. to Lead the Market 

The report also provides profiles of leading players operating in the global pediatric health care products and services market. These include Pfizer, Inc., GlaxoSmithKline plc. Merck & Co., Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Gilead Sciences, Inc., Sanofi, Pediapharm, Inc., Novartis AG, Eisai Co., Ltd., and Mylan N.V.

Popular Research Reports by TMR: 

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]

Website: http://www.transparencymarketresearch.com

Research Blog: https://theglobalhealthnews.com/



These press releases may also interest you

at 06:30
Boston Scientific Corporation generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior...

at 06:28
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pharma Parenteral Packaging Market ? By Drug Type (Small Molecules, Biologics, Vaccines, Biosimilars, & Others), By Product Type (Bottles, Ampoules,...

at 06:15
Overall 8.46 Average Revised Venous Clinical Severity Score (rVCSS) Improvement Per Patient for Patients Showing Clinical Meaningful Benefit (rVCSS Improvement ≥ 3 Points) including:9.29 Points for Patients at the Two-Year Milestone8.08 Points...

at 06:10
Thermo Fisher Scientific Inc. , the world leader in serving science, will hold its 2024 Investor Day on Thursday, September 19, starting at 9:00 a.m. (ET) in New York City. The format will feature presentations by members of Thermo Fisher...

at 06:05
Thermo Fisher Scientific Inc. , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP...

at 06:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8. Biodesix's...



News published on and distributed by: